Ertugliflozin plus sitagliptin versus either individual agent over 52 weeks in patients with type 2 diabetes mellitus inadequately controlled with metformin: The VERTIS FACTORIAL randomized trial - Pratley, R E; Eldor, R; Raji, A (Diabetes Obes Metab, 2018)
et al.